Contract Research Services
ImQuest BioSciences is a preclinical CRO that provides expert services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. These preclinical research services are part of our ImQuestSUCCESS Platform and include compound screening to define compound efficacy and drug target validation to define the mechanism of action and toxicity of pharmaceutical products.
We provide preclinical services in the following areas:
- In vitro Toxicology
- Women's Health
- Pharmaceutical Properties and Characterization
- Microbicides and STI Prevention
- Supportive Technical Services
- Consulting Services
We specialize in services for the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines. Our Services.
We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in preclinical contract research. As such, we understand that each product and each client is unique and we strive to provide effective solutions. About Us.
Combination Therapy Key to Fighting Bacterial Infections
Current antibiotic treatments include using one or two drugs to fight an infection, and these treatments are becoming less and less effective as bacteria and other pathogens continue to develop and spread resistance mechanisms against them.
Preclinical Contract Research Services